PMV Pharmaceuticals, Inc.
PMVP
$1.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 130.74% | -10.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.99% | 8.52% | |||
| Operating Income | -14.99% | -8.52% | |||
| Income Before Tax | -20.09% | -10.16% | |||
| Income Tax Expenses | -100.00% | 100.46% | |||
| Earnings from Continuing Operations | -19.63% | -1,485.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.63% | -1,485.00% | |||
| EBIT | -14.99% | -8.52% | |||
| EBITDA | -16.79% | -8.68% | |||
| EPS Basic | -19.07% | -1,479.66% | |||
| Normalized Basic EPS | -19.52% | -9.95% | |||
| EPS Diluted | -19.07% | -1,479.66% | |||
| Normalized Diluted EPS | -19.52% | -9.95% | |||
| Average Basic Shares Outstanding | 0.47% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||